Risk Factors for Venous Thromboembolism

Pulmonary Embolism Clinical Trial

Official title:

2779 Epidemiology of Genetic and Acquired Risk Factors for Venous Thrombosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00018772
• Other study ID #: HEMA-013-98F
• Status: Completed
• Phase: N/A
• First received: July 3, 2001
• Last updated: January 20, 2009
• Start date: April 1999
• Est. completion date: April 2003

Study information

• Verified date: December 2004
• Source: VA Office of Research and Development
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

Deep venous thrombosis is the presence of blood clots, usually in the legs that lead to either local problems or breathing problems if the clot moves to the lungs. This study is designed to assess both clinical conditions as well as common genetic factors that lead to more risk of deep venous thrombosis. Clinical conditions of venous thrombosis include: stroke, malignancy, and situations such as surgery, pregnancy, trauma, or travel.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: April 2003
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Patients must be 18 years with the ability to understand and consent to questionnaire and blood draw, including understanding of genetic testing..

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Deep Venous Thrombosis
• Pulmonary Embolism
• Thrombosis
• Venous Thrombosis

Locations

Country	Name	City	State
United States	VAMC	Denver	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States,